Carestream starts shipping mobile DR

Lisa Fratt | | Health Imaging | Diagnostic Imaging
Carestream Health in Rochester, N.Y., has started shipping its DRX-Revolution mobile x-ray system.

The DRX-Revolution includes a software tool that creates companion images from the original exposure: one image shows tubes and lines so physicians can verify placement, and another accentuates the appearance of free air in the chest cavity for visualization of the pneumothorax, according to the company.

The DRX-Revolution also includes an extendable tube head and two monitors (the main 19-inch monitor and an eight-inch tube head monitor), which allows a technologist to capture and review images without moving away from a patient’s bed.

Lisa Fratt

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.